Â¥
14.73
Sep 13
New Key Statistics Module, Z-Score and F-Score
SZSE:002603 Key Ratios
Market Cap ¥ M | 24,609.49 |
Enterprise Value ¥ M | 24,870.31 |
P/E(ttm) | 88.73 |
PE Ratio without NRI | 74.39 |
Forward PE Ratio | 14.38 |
Price/Book | 2.14 |
Price/Sales | 3.03 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 2.53 |
Revenue (TTM) ¥ M | 8,132.00 |
EPS (TTM) ¥ | 0.17 |
Beneish M-Score | -1.55 |
10-y EBITDA Growth Rate % | 20.90 |
5-y EBITDA Growth Rate % | 26.10 |
y-y EBITDA Growth Rate % | -87.50 |
EV-to-EBIT | 56.87 |
EV-to-EBITDA | 56.87 |
PEG | 2.85 |
Shares Outstanding M | 1,670.71 |
Net Margin (%) | 3.40 |
Operating Margin % | 6.65 |
Pre-tax Margin (%) | 4.85 |
Quick Ratio | 1.06 |
Current Ratio | 1.49 |
ROA % (ttm) | 1.60 |
ROE % (ttm) | 2.38 |
ROIC % (ttm) | 2.94 |
Dividend Yield % | 2.02 |
Altman Z-Score | 4.03 |
SZSE:002603 Number of Guru Trades
SZSE:002603 Volume of Guru Trades
Gurus Latest Trades with SZSE:002603
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002603 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shijiazhuang Yiling Pharmaceutical Co Ltd Insider Transactions
No Available Data